causal

Oxford Vaccine Delayed by Anti-Profit Stance

The Oxford team invented a working vaccine formula but, philosophically opposed to for-profit companies, broke their deal with Merck (which could manufacture and distribute at scale) and instead partnered with AstraZeneca, which promised no profit; this decision delayed the vaccine's rollout by about three months at tremendous cost.

causalpending

Speaker

Casey Mulligan

Evidence Quote

“they fired Merck because they were going to earn a profit and that's evil.”

Source

Casey Mulligan on Vaccines, the Pandemic, and the FDA— EconTalk
Created: 6/13/2026, 12:24:14 AM

Your notes

Loading notes...